Schedule 13G ownership disclosure

Clearmind Medicine Inc.

Common shares, no par value · CUSIP: 185053709

Event date: 2026-10-20

Filing-level shares
25,300.00
Percent of class
4.9%
  • Gainor Lewis Berray

    Shares: 25,300.00 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002161378-26-000002
Form type
SCHEDULE 13G
Filer
Gainor Lewis Berray
CIK
CIK 2161378
Filed
Oct 27, 2026
Reporting period
Oct 20, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub